Why Bonicel

Founded in 1997 the Cleveland, Ohio-based Ganeden is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies for the food, beverage, animal health, and now cosmeceutical ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS probiotic ingredient found in more than 85 leading food and beverage products. A highly stable probiotic ingredient with physical properties that make it more stable than traditional probiotic organisms (such as Lactobacillus and Bifidobacterium); GanedenBC30 is ideally suited for almost any food, beverage or animal health application. Ganeden\'s newest ingredient, Bonicel, is the first patented, probiotic-derived, topical cosmeceutical ingredient shown to dramatically reduce the visible signs of aging. It can easily be incorporated in virtually any lotion, cream, soap, shampoo or other personal care product.  For more information about Ganeden visit GanedenProbiotics.com.

Other “Probiotic” skin care products may IMPROPERLY claim:

  • Live cells grow on the skin
  • Combinations of pre/probiotics accelerate growth
  • The use of bacterial DNA has a positive effect
  Bonicel Others
Clinically Tested Yes No
Supported By Science Yes No
Live Cells No No
Derived from GRAS Organism Yes No
Patent Protected Worldwide Yes No
Easy to Formulate Yes No

Ganeden protects their partners with over 100 issued patents worldwide, with dozens more pending.

Ganeden values partnership.
We are more than a supplier – we are partners.

  • A typical Purchase & License agreement for Bonicel includes a license for patent and trademark use, along with the use of all clinical data.
  • Ganeden’s world class labs and affiliated research organizations all become part of our partners’ R&D teams.
  • Ganeden’s rapid development processes help our partners take products from concept to market in less time.
  • Ganeden will give each partner the support they need through content development, marketing and clinical support plus much, much more:
    • Formulation considerations
    • Safety & clinical data support
    • Storage and handling
    • Claims and label requirements
    • Marketing, PR & launch planning

Some other tidbits:

  • Ganeden has 17 published studies since 2009 including a safety study and clinical trials
  • FDA GRAS No Objection Letter
  • Several more manuscripts in and even more studies in progress
  • Ganeden has an experienced management team with backgrounds in human and animal health, B2B, B2C, IP and a variety of scientific disciplines.
  • Ganeden partners with leading food and beverage, personal care, consumer product and research organizations worldwide to collaborate on:
    • Product development
    • Research and development
    • Marketing and education
    • Clinical application development